Beilstein J. Org. Chem. 2016, 12, 1170–1177.
4. Hommes, P.; Fischer, C.; Lindner, C.; Zipse, H.; Reissig, H.-U.
Angew. Chem., Int. Ed. 2014, 53, 7647–7651.
Conclusion
In this report we could show that the scope of the cycloconden-
sation reaction of β-ketoenamides 3 leading to unsymmetrically
substituted bipyridine derivatives 5 is fairly broad and compati-
ble with various functional groups. Only substrates such as 3h
having no “superfluous” substituents did not provide the ex-
pected bipyridine skeleton. Substrates 3 with higher substitu-
tion degree provided the expected bipyridine derivatives that
were directly converted into the corresponding nonafloxy-
substituted compounds 5 in good overall yield. These are excel-
lent precursors for palladium-catalyzed coupling reactions as
exemplified by the synthesis of compounds such as 9–13. By an
attempt to prepare the methoxy-substituted β-ketoenamide 3i by
oxidative methoxylation of compound 3a we unexpectedly ob-
served the formation of the 5-acetyl-substituted oxazole deriva-
tive 6. However, precursor 3i was smoothly available from
acetylacetone 1a. It could smoothly be transformed into the
desired bipyridine derivative 4i, but also into the related pyrimi-
dine and pyrimidine N-oxide derivatives 7 and 8. Altogether,
we could confirm that our approach to functionalized pyridine
derivatives by cyclocondensation of β-ketoenamides is also
a very versatile and flexible method for the synthesis of un-
symmetrically substituted bipyridine derivatives or related
heterocyclic compounds that are not accessible by alternative
methods.
5. Hommes, P.; Jungk, P.; Reissig, H.-U. Synlett 2011, 2311–2314.
6. Chelucci, G.; Thummel, R. P. Chem. Rev. 2002, 102, 3129–3170.
7. Kaes, C.; Katz, A.; Hosseini, M. W. Chem. Rev. 2000, 100, 3553–3590.
8. Schubert, U. S.; Eschbaumer, C. Angew. Chem., Int. Ed. 2002, 41,
2892–2926.
Angew. Chem. 2002, 114, 3016–3050.
9. Fletcher, N. C. J. Chem. Soc., Perkin Trans. 1 2002, 1831–1842.
10.Newkome, G. R.; Patri, A. K.; Holder, E.; Schubert, U. S.
11.Ye, B.-H.; Tong, M.-L.; Chen, X.-M. Coord. Chem. Rev. 2005, 249,
12.Hapke, M.; Brandt, L.; Lützen, A. Chem. Soc. Rev. 2008, 37,
13.Gütz, C.; Lützen, A. Synthesis 2010, 85–90.
14.Bozic-Weber, B.; Constable, E. C.; Housecroft, C. E.; Kopecky, P.;
Neuburger, M.; Zampese, J. A. Dalton Trans. 2011, 40, 12584–12594.
15.Duric, S.; Tzschucke, C. C. Org. Lett. 2011, 13, 2310–2313.
Supporting Information
16.Okamoto, S. Heterocycles 2012, 85, 1579–1602.
Supporting Information File 1
17.Duric, S.; Sypaseuth, F. D.; Hoof, S.; Svensson, E.; Tzschucke, C. C.
18.Kremer, C.; Schnakenburg, G.; Lützen, A. Beilstein J. Org. Chem.
General information, all experimental procedures and
analytical data as well as copies of NMR spectra of all
compounds.
19.Guo, Z.; Tong, W.-L.; Chan, M. C. W. Chem. Commun. 2014, 50,
20.Renfrew, A. K.; Bryce, N. S.; Hambley, T. Chem. – Eur. J. 2015, 21,
21.Gao, Y.; Zhang, Q.; Xu, J. Synth. Commun. 2004, 34, 909–916.
Acknowledgements
This work was generously supported by the Deutsche
Forschungsgemeinschaft and by Bayer HealthCare. We thank
Dr. Tilman Lechel and Birte Mull for preliminary experiments
for the synthesis of compound 5a and Dr. Reinhold Zimmer for
his help during the preparation of this article.
22.Ji, Y.; Trenkle, W. C.; Vowles, J. V. Org. Lett. 2006, 8, 1161–1163.
23.Li, X.; Du, Y.; Liang, Z.; Li, X.; Pan, Y.; Zhao, K. Org. Lett. 2009, 11,
24.Baraldi, P. G.; Barco, A.; Benetti, S.; Manfredini, S.; Pollini, G. P.;
Simoni, D. Tetrahedron 1987, 43, 235–242.
References
1. Dash, J.; Reissig, H.-U. Chem. – Eur. J. 2009, 15, 6811–6814.
25.Katritzky, A. R.; He, H.-Y.; Suzuki, K. J. Org. Chem. 2000, 65,
26.Katritzky, A. R.; Suzuki, K.; Wang, Z. Synlett 2005, 1656–1665.
2. Eidamshaus, C.; Reissig, H.-U. Eur. J. Org. Chem. 2011, 6056–6069.
27.Mosher, H. S.; Look, M. J. Org. Chem. 1955, 20, 283–286.
3. Hommes, P.; Berlin, S.; Reissig, H.-U. Synthesis 2013, 45, 3288–3294.
28.Bankston, D.; Dumas, J.; Natero, R.; Riedl, B.; Monahan, M.-K.;
Sibley, R. Org. Process Res. Dev. 2002, 6, 777–781.
1176